Internal Medicine Alert
RSSArticles
-
Treating Erectile Dysfunction After Myocardial Infarction May Be Safe
In a Swedish nationwide cohort study of men < 80 years of age hospitalized for myocardial infarction, treatment for erectile dysfunction with phosphodiesterase-5 inhibitors resulted in lower mortality and heart failure hospitalization.
-
Considering More Intensive Blood Pressure Control in the Elderly
In elderly, hypertensive patients, intensive blood pressure (BP) control (systolic BP < 140 mmHg) decreased major adverse cardiovascular events, including cardiovascular mortality and heart failure.
-
Clinical Briefs
In this section: a connection between atopic dermatitis and autoimmune disorders; association of sickle cell trait with hemoglobin; and the continuing search for dementia triggers.
-
Naldemedine Tablets (Symproic) C-II
Naldemedine is indicated for the treatment of opioid-induced constipation in adults with chronic noncancer pain.
-
Vitamin D to Prevent Acute Respiratory Infections?
Vitamin D supplementation is associated with a decreased risk of respiratory infections, especially in those who had low circulating levels of 25-hydroxyvitamin D.
-
Migraine: Differences Between Males and Females
Hormonal and genetic differences factor into a greater prevalence and disability burden of migraine in teenaged girls and women; however, migraine is underdiagnosed and inadequately treated in boys and men.
-
Troponin Highly Prognostic in Decompensated Heart Failure With Preserved Ejection Fraction
Among patients with acute decompensated heart failure and preserved ejection fraction, elevated troponin is associated with worse in-hospital outcomes and long-term survival, independent of other predictors.
-
Ventricular Tachycardia, Supraventricular Tachycardia With Right Bundle Branch Block, or Something Else?
-
Clinical Briefs
In this section: recognizing signs of binge eating disorder; a closer look an antisocial behavioral problems; and treating sickle cell pain.
-
Desmopressin Acetate Nasal Spray (Noctiva)
Desmopressin nasal spray is indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least twice per night to void.